Back to discover
Disease
Asthenia
Late-stage therapeutic developmentEmerging research
1
Publications
4
Clinical trials
2020
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia.
Research2020-03-06Journal of cachexia, sarcopenia and muscle
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
4
0
4
2
Late-stage studies
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Leading journals1
- Journal of cachexia, sarcopenia and muscle1
Leading researchers5
- Costa E Silva MP1
- Gil da Costa RM1
- Medeiros R1
- Peixoto da Silva S1
- Santos JMO1
Affiliations (unnormalised)6
- Biomedical Research Center (CEBIMED)1
- Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB)1
- Faculty of Medicine of the University of Porto (FMUP)1
- Federal University of Maranhão (UFMA)1
- IPO Porto Research Center (CI-IPOP)1
- Portuguese Oncology Institute of Porto (IPO Porto)1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.